| Literature DB >> 35059715 |
Jiajun Li1, Xin Zheng1, Xiong Li1, Jing Yang2, Wei Liu1, Lei Yang3, Bin Liu1.
Abstract
Patients receiving pelvic or abdominal radiotherapy may experience acute and/or chronic side effects due to gastrointestinal changes. However, effective medicine for treating radiation enteritis has not been found yet. Sargentodoxa cuneata is a famous Chinese medicine used to treat intestinal inflammation, and our research team has found the main biologically active compound through its extraction, which is Liriodendrin. In this study, we found that Liriodendrin can reduce the expression of Cer, Cer1P and S1P in the sphingolipid pathway, thereby reducing the histological damage to the intestinal tract of mice and inhibiting the apoptosis of intestinal tissue cells. In addition, Liriodendrin can reduce the levels of pro-inflammatory cytokines (IL-6 and TNF-α), and it is suggested through flow cytometry that the proportion of neutrophils in the intestinal tissue can decrease due to the existence of Liriodendrin. At the same time, the western blot evaluation revealed that Liriodendrin significantly inhibited the activation of Bcl-2/Bax/Caspase-3 and NF-κB signaling pathways. The results show that Liriodendrin can inhibit intestinal inflammation and intestinal cell apoptosis through the sphingolipid pathway. Therefore, the aforementioned results demonstrated that Liriodendrin may be a promising drug for the treatment of radiation enteritis.Entities:
Keywords: Liriodendrin; anti-apoptosis; anti-inflammatory activity; radiation enteritis; sphingolipid
Mesh:
Substances:
Year: 2022 PMID: 35059715 PMCID: PMC8944324 DOI: 10.1093/jrr/rrab128
Source DB: PubMed Journal: J Radiat Res ISSN: 0449-3060 Impact factor: 2.724
Fig. 1.The protective effect of Liriodendrin on radiation enteritis in mice (100 μm). (A) the effect of Liriodendrin on the pathological damage of the intestinal tract of mice; (B) the histological score of pathological damage. (##: IR group vs control group P < 0.01; *: IR + LD group vs IR group P < 0.05). (C) Compared with the control group, the expressions of Cer, Cer1P and S1P were increased in the IR group. Compared with the IR group, the IR + LD group found that Liriodendrin can reduce the expression of Cer, Cer1P and S1P. (##: IR group vs control group P < 0.01; #: IR group vs control group P < 0.05; **: IR + LD group vs IR group P < 0.01; *: IR + LD group vs IR group P < 0.05).
Fig. 2.During radiation enteritis, Liriodendrin can inhibit the production of p-NF-protein and pro-inflammatory cytokines. (A) Liriodendrin reduces the content of p-NF-κB protein. (B, C) Liriodendrin reduces the mRNA levels of the pro-inflammatory cytokines IL-6 and TNF-α. The western blotting experiment and real-time PCR detection were repeated (*P < 0.05, **P < 0.01).
Fig. 3.Liriodendrin reduces the proportion of neutrophils in the small intestine tissue. CD45+/CD11b+/Ly6G+ cells represent neutrophils. (A) The proportion of neutrophils in the small intestine tissue of each group. (B) Comparison of the proportion of CD11b+ + Ly6G+ cell population to CD45+ cell population in small intestine tissue (**P < 0.01).
Fig. 4.Liriodendrin can reduce cell apoptosis after radiation. (A) Liriodendrin reduces radiation-induced apoptosis (100 μm). The apoptosis was analyzed by the TUNEL assay and the number of TUNEL+ cells was counted. The results are drawn from at least 15 areas. (B) Liriodrin can down-regulate the levels of BAX and Caspase-3, and up-regulate the levels of Bcl-2. Quantification of BAX (C), BCL-2 (D) and Caspase-3 (E). (* < 0.05, ** P <0.01).